{"organizations": [], "uuid": "da2d9bd9feca6ac38e64eb7c6a65a5375d630c5e", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180125.html", "section_title": "Archive News &amp; Video for Thursday, 25 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-generon-corp-says-successfully-con/brief-generon-corp-says-successfully-concluded-first-phase-iii-clinical-trial-of-f-627-idUSASB0C29D", "country": "US", "domain_rank": 408, "title": "BRIEF-Generon Corp Says Successfully Concluded First Phase III Clinical Trial Of F-627", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.99, "site_type": "news", "published": "2018-01-25T13:14:00.000+02:00", "replies_count": 0, "uuid": "da2d9bd9feca6ac38e64eb7c6a65a5375d630c5e"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-generon-corp-says-successfully-con/brief-generon-corp-says-successfully-concluded-first-phase-iii-clinical-trial-of-f-627-idUSASB0C29D", "ord_in_thread": 0, "title": "BRIEF-Generon Corp Says Successfully Concluded First Phase III Clinical Trial Of F-627", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "brief-generon corp", "sentiment": "negative"}, {"name": "generon corp", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 25 (Reuters) -\n* GENERON SUCCESSFULLY CONCLUDES FIRST PHASE III CLINICAL TRIAL OF F-627 FOR CHEMOTHERAPY-INDUCED NEUTROPENIA\n* GENERON CORP- PATIENTS TREATED WITH F-627 DEMONSTRATED SIGNIFICANTLY REDUCED DURATION OF SEVERE NEUTROPENIA COMPARED TO PATENTS IN PLACEBO GROUP â€‹ Source text for Eikon:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-25T13:14:00.000+02:00", "crawled": "2018-01-26T21:07:24.000+02:00", "highlightTitle": ""}